Evidence map›Paper›PMID 38893674›Full record

ReviewDiagnostics (Basel, Switzerland)2024

Co-Infection of SARS-CoV-2 and

Angelica de Lima das Chagas, Joilma Cruz da Silva Araújo, Jaqueline Correia Pontes Serra, Kelliane Martins de Araújo, Marcos de Oliveira Cunha, Amanda Dos Reis Correia, Laura Maria Barbosa Gonçalves, Lilian Carla Carneiro

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Gut microbial allies and adversaries in SARS-CoV-2 infection.Current research in microbial sciences · 2026
    Article
  2. Article
  3. Association of nasopharyngealMicrobiology spectrum · 2026
    Article
  4. Impact of the COVID-19 Pandemic on Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Prevalence of hypervirulentFrontiers in microbiology · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Angelica de Lima das ChagasHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0003-3085-3955
Joilma Cruz da Silva AraújoPharmacy Faculty, Federal University of Goias, Goiania 74605-170, Goias, Brazil.ORCID 0009-0002-2183-8470
Jaqueline Correia Pontes SerraHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0001-9712-8534
Kelliane Martins de AraújoHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0002-5694-1331
Marcos de Oliveira CunhaHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0001-6255-1818
Amanda Dos Reis CorreiaHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0001-5378-7140
Laura Maria Barbosa GonçalvesPostgraduate Program in Biology of Host Parasite Relationship, Federal University of Goias, Goiania 74690-900, Goias, Brazil.ORCID 0009-0005-1585-1347
Lilian Carla CarneiroHealth Science Post Graduation, Federal University of Goias, Goiania 74605-050, Goias, Brazil.ORCID 0000-0003-4067-1506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study aimed to assess the prevalence of COVID-19 and

Indexed as

bacteriumepidemiologyvirology

Identifiers

PMID38893674
PMCPMC11171625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.